Study Stopped
PI left University of Minnesota
Assessing the Effectiveness of Two Treatment Strategies for Tension-type Headache
1 other identifier
interventional
N/A
1 country
2
Brief Summary
The primary aim of the pilot data proposal is to compare usual care (medications) versus multi-disciplinary treatment in temporomandibular disorder (TMD) patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Apr 2012
Typical duration for phase_3
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2011
CompletedFirst Posted
Study publicly available on registry
May 4, 2011
CompletedStudy Start
First participant enrolled
April 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedDecember 7, 2016
December 1, 2016
3.2 years
April 28, 2011
December 6, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change from baseline of headache intensity of pain using pain scale of 1-10
3 months
Study Arms (2)
Standard care using current drugs
ACTIVE COMPARATORStandard care with drug intervention
Behavioral therapy, splint therapy and physical therapy
EXPERIMENTALUsing rehabilitation for comparing use of drug
Interventions
Includes patient education, use of a mouth guard, jaw muscle exercises and brief cognitive-behavioral intervention.
Eligibility Criteria
You may qualify if:
- Fifty consecutive subjects (Age 18 to 65) will be included when they fulfill the diagnostic criteria for episodic or chronic TTH with pericranial muscle tenderness3 and TMD including myofascial pain involving the temporalis muscle -
You may not qualify if:
- systemic rheumatic disease
- widespread pain
- pregnancy
- concurrent use of tricyclic antidepressants, steroids, anti-inflammatories, muscle relaxants, or narcotics
- major psychiatric disease
- any medical contraindications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of Minnesota School of Dentistry
Minneapolis, Minnesota, 55455, United States
University of Minnesota
Minneapolis, Minnesota, 55455, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Eric L Schiffman, DDS
University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 28, 2011
First Posted
May 4, 2011
Study Start
April 1, 2012
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
December 7, 2016
Record last verified: 2016-12